Development of a smartphone based quantum-dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies

Jinfeng Li,Bochao Liu,Xi Tang,Ze Wu,Jinhui Lu,Chaolan Liang,Shuiping Hou,Ling Zhang,Tingting Li,Wei Zhao,Yongshui Fu,Yuebin Ke,Chengyao Li
DOI: https://doi.org/10.1016/j.ijid.2022.04.042
IF: 12.073
2022-04-01
International Journal of Infectious Diseases
Abstract:Background: As several vaccine candidates for SARS-CoV-2 have been developed, a large proportion of people has be vaccinated worldwide so far. The rapid and accurate immunoassays are urgently demanded for detecting specific virus-neutralizing antibody (NAb), which reflect the protective effect of the vaccines among different populations.Methods: In this study, we designed a quantum-dot lateral flow immunoassay strip (QD-LFIA) on smartphone for detection of specific IgG or neutralizing antibodies to SARS-CoV-2 in human serum or whole blood samples. The recombinant receptor binding domain (RBD) of SARS-CoV-2 spike protein was used as the antigen to combine with NAb or angiotensin-converting enzyme 2 (ACE2).Results: Among 81 recovered COVID-19 patients diagnosed with NAT initially, 98.8% (80/81) were positive for IgG and 88.9% (72/81) were positive for NAb by QD-LFIA. Among 64 inactivated vaccine and 6 subunit vaccine inoculated vaccinees, 90% (63/70) were positive for IgG and 82.9% (58/70) were positive for NAb by QD-LFIA, while no cross-reaction was found from 150 healthy blood donor, 2 Flu B and 3 common cold patients.Conclusions: The established platform could achieve a rapid and accurate detection of NAb specific to SARS-CoV-2, which could be used for detecting the protective effect of the vaccines in epidemic areas of world.
infectious diseases
What problem does this paper attempt to address?